Recent Publications on ESRD Kidney Failure Dialysis: |  |
| [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report.]
| 21st November, 2009
| Unita' Operativa Complessa di Nefrologia e Dialisi, ULSS N. 2 Feltre,
|
Sodium Bicarbonate Plus N-Acetylcysteine Prophylaxis A Meta-Analysis.
OBJECTIVES: We sought to conduct a meta-analysis to compare... Direct Link | 21st November, 2009
| The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon,
|
| Use of sorafenib in two metastatic renal cell cancer patients with end-stage renal impairment undergoing replacement hemodialysis.
| 18th November, 2009
| Oncologia Medica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
|
| Effect of darbepoetin alfa on renal anemia in Japanese hemodialysis patients.
| 17th November, 2009
| Division of Nephrology, Nantan General Hospital, Kyoto, Japan.
|
An improved comorbidity index for outcome analyses among dialysis patients.
Since comorbid conditions are highly prevalent among patients with... Direct Link | 13th November, 2009
| United States Renal Data System, Minneapolis, Minnesota, USA.
|
Estimates of risk, empirical treatment observations, and unexpected laboratory findings reveal the complexity of nephrogenic systemic fibrosis.
Antihypertensive treatment is an essential, life-prolonging measure in... Direct Link | 11th November, 2009
|
|
UV-A1 therapy for nephrogenic systemic fibrosis.
BACKGROUND: Nephrogenic systemic fibrosis (NSF) is a rare sclerosing skin... Direct Link | 11th November, 2009
| Department of Dermatology, University of Texas-Southwestern Medical Center
|
Associations of Adiponectin with Paraoxonase 1 and sE-Selectin in Hemodialyzed Patients.
Background/Aims: In hemodialyzed (HD) patients, adiponectin and... Direct Link | 6th November, 2009
| Institute of Laboratory Medicine, University of Pecs, Pecs, Hungary.
|
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease.
BACKGROUND: Anemia is associated with an increased risk of cardiovascular... Direct Link | 3rd November, 2009
| The affiliations of the authors are listed in the Appendix. This article
|
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
CONTEXT: Cardiovascular mortality is considered the main cause of death in... Direct Link | 3rd November, 2009
| Department of Clinical Epidemiology, Leiden University Medical Center,
|
The angiotensin II type 2 receptor in renal disease.
Suppression of angiotensin II formation by angiotensin-converting enzyme... Direct Link | 29th October, 2009
| Department of Medicine, Division of Nephrology, University Hospital
|
Impact of pancreas transplantation on the quality of life of diabetic renal transplant recipients.
Simultaneous pancreas and kidney transplantation (SPKT) is considered to... Direct Link | 28th October, 2009
| Department of General, Vascular, and Transplant Surgery, Medical
|
Kidney Transplantation in the Context of Renal Replacement Therapy.
Kidney transplantation has dramatically evolved from a life-saving yet... Direct Link | 24th October, 2009
| Ohio State University, Columbus, Ohio.
|
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.
Increased plasma levels of asymmetric dimethylarginine (ADMA) are... Direct Link | 23rd October, 2009
| Department of Medicine, Renal Section, Toensberg County Hospital,
|
| Should we prescribe blood pressure lowering drugs to every patient with advanced chronic kidney disease? A comment on two recent meta-analyses.
| 23rd October, 2009
|
|